Table 2.
Clinical outcomes
| Outcomes | Group | p value | |
|---|---|---|---|
| Control n = 73 |
NMES n = 76 |
||
| Mortality in ICU, n (%) | 4 (6%) | 6 (8%) | 0.75 |
| Length of stay in ICU, days | 8.4 ± 7.7 | 6.6 ± 7.6 | 0.04* |
| Time on MV, days | 4.6 ± 3.2 | 5.8 ± 4.1 | 0.41 |
| IMS at ICU discharge | 1.0 [0.0–5.0] | 1.0 [1.0–6.0] | 0.21 |
| Braden score at ICU discharge | 14.6 ± 3.1 | 15.1 ± 3.3 | 0.34 |
| Incidence of sepsis, n (%) | 7 (9.6%) | 7 (9.2%) | 0.93 |
| Use of analgesic drugs, n (%) | 73 (100%) | 76 (100%) | 0.99 |
| Use of sedative drugs, n (%) | 42 (57.5%) | 37 (48.7%) | 0.27 |
| Use of vasopressor drugs, n (%) | 21 (28.8%) | 19 (25.0%) | 0.60 |
| Use of corticosteroid drugs, n (%) | 41 (56.2%) | 38 (50.0%) | 0.45 |
| Day of PI development | 5.8 ± 3.1 | 8.3 ± 2.6 | 0.09 |
NMES: neuromuscular electrical stimulation; MV: mechanical ventilation; IMS: intensive care unit mobility scale; PI: pressure injury; ICU: intensive care unit; n (%): absolute and relative frequency
Variables are reported as mean (± standard deviation) or as median and [interquartile range]. P values were calculated using the Fisher's exact test, Student's t test for independent groups (assuming homogeneity of variances), and Mann–Whitney test according to each data distribution and characteristics. *p values ≤ 0.05